Molecular Therapy

Article	Citations
Vaccine Technologies Jockey for Primacy in Pandemic Response	473
The high efficacy of claudin18.2-targeted CAR-T cell therapy in advanced pancreatic cancer with a strategy to ensure the safety of patients	196
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors	179
ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD	172
A functional RNA-origami as direct thrombin inhibitor with fast-acting and specific single-molecule reversal agents in vivo model	172
RNA and epigenetic editing: The new frontier in gene and cell therapy	157
Promotion or inhibition? This is a question in gene editing	157
Mapping the cancer surface proteome in search of target antigens for immunotherapy	156
Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis	154
BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism	147
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo	145
Response to: DNA transposon mechanisms and pathways of genotoxicity	141
CRISPR-Cas9 as a Trojan horse	140
Prospects and challenges of tissue-derived extracellular vesicles	135
Discovery of a novel inhibitor of macropinocytosis with antiviral activity	125
XGBoost framework with feature selection for the prediction of RNA N5-methylcytosine sites	122
The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity	120
Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier	118
Corticosteroids and mRNA Vaccines: A Word of Caution	118
Reversing the path: Mesenchymal-to-mesothelial transition as a novel target in liver fibrosis	112
Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD	108
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques	106
A “Shot in the Arm” for Sickle Cell Disease	106
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19	106
Call for papers: Exploiting extracellular vesicles as therapeutic agents	103

A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth	100
DUX4 Transcript Knockdown with Antisense 2′-O-Methoxyethyl Gapmers for the Treatment of Facioscapulohumeral Muscular Dystrophy	99
An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers	97
Base editing the synapse: Modeling a complex neurological disorder in non-human primates	95
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial	94
Targeting of miR-33 ameliorates phenotypes linked to age-related macular degeneration	93
In this issue	93
Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex	93
ASGCT 27th Annual Meeting Late-Breaking Abstracts	92
2022 ASGCT Annual Meeting Late-breaking Abstracts	92
Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease	91
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors	86
Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1	85
FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis	85
Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population	84
mRNALocater: Enhance the prediction accuracy of eukaryotic mRNA subcellular localization by using model fusion strategy	84
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ	83
Tissue nanotransfection causes tumor regression by its effect on nanovesicle cargo that alters microenvironmental macrophage state	80
Clarin-2 gene supplementation durably preserves hearing in a model of progressive hearing loss	78
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy	75
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery	73
Global challenges in preparedness and response to epidemic infectious diseases	73
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes	72
Heal thyself: The promise of autologous hematopoietic stem cell gene therapy in neurometabolic disorders	70
Preclinical evaluation of ADVM-062, a novel intravitreal gene therapy vector for the treatment of blue cone monochromacy	70
Beyond the unfolded protein response: Disclosing the role of XBP1s in Alzheimer’s disease	69
Mavis Agbandje-McKenna’s lifelong commitment to teaching and research	69
The first medical education program on gene and gene-modified cell therapies for Latin America	67
Collaborative science to advance gene therapies in resource-limited parts of the world	67
Financial considerations in expanded access policy for gene therapies: A tough nut to crack?	67
Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene	67
In this issue	66
In vivo genome editing for inherited retinal disease: Opportunities and challenges	66
Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter	65
Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy	64
Inhibition of adenylyl cyclase 8 prevents the upregulation of Orai1 channel, which improves cardiac function after myocardial infarction	64
Antitumor activity of a lectibody targeting cancer-associated high-mannose glycans	62
In this issue	62
AAV and hepatitis: Cause or coincidence?	62
circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFβR1/VEGF-D signaling	61
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia	61
Treatment-induced hemophilic thrombosis?	60
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer	60
Accessorizing viral vectors with extracellular vesicles for enhanced performance	60
Advances and transgressions of nuclear transport checkpoint inhibitors	59
Three recent breakthroughs in CAR T cells for the treatment of glioblastoma: Is it the light at the end of the tunnel?	59
VCAM-targeting lipid platform brings new hope to the treatment of ischemic stroke	58
Expanding strategies to resolve psoriasis-like inflammation: Non-canonical NF-κB signaling controls IL-23 production in dendritic cells	57
Envelope protein-specific B cell receptors direct lentiviral vector tropism in vivo	57
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes	56

Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice	56
SOCS3 regulates pathological retinal angiogenesis through modulating SPP1 expression in microglia and macrophages	56
Mechanical force determines chimeric antigen receptor microclustering and signaling	55
Reply to In vivo confusion over in vivo conversion	55
SOD2 promotes the immunosuppressive function of mesenchymal stem cells at the expense of adipocyte differentiation	55
Hitchhiking of Cas9 with nucleus-localized proteins impairs its controllability and leads to efficient genome editing of NLS-free Cas9	55
Large-scale falsification of research papers risks public trust in biomedical sciences	54
Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction	54
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies	53
Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders	53
Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection	52
Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease	52
Immune responses to cells and proteins after hematopoietic stem cell gene therapy for inherited diseases: A cause for concern	50
Integrative proteomic and metabolomic elucidation of cardiomyopathy with in vivo and in vitro models and clinical samples	50
Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity	49
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma	49
Blunting specific T-dependent antibody responses with engineered “decoy” B cells	48
CITED4 gene therapy: Can it be cited for preventing maladaptive post-ischemic cardiac remodeling?	48
The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation	48
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo	48
Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells	48
High-throughput screening identifies ibuprofen as an sEV PD-L1 inhibitor for synergistic cancer immunotherapy	48
Precision spinal gene delivery-induced functional switch in nociceptive neurons reverses neuropathic pain	47
Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment	47
FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner	47
Emerging roles of the crosstalk between non-coding RNAs and m6A modification in cancers	47
Presidential Symposium and Presentation of Top Abstracts	47
Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapy	47
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasms	46
AAV vector manufacturing process design and scalability - Bending the trajectory to address vector-associated immunotoxicities	46
The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant	45
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells	45
Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma	45
Increasing the Specificity of AAV-Based Gene Editing through Self-Targeting and Short-Promoter Strategies	44
Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy	44
A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia	44
Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides	44
Successful large gene augmentation of USH2A with non-viral episomal vectors	44
Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells	44
Modulation of NLRP3 inflammasomes activation contributes to improved survival and function of mesenchymal stromal cell spheroids	44
Oncolytic Viruses for Systemic Administration: Engineering a Whole Different Animal	43
IL-1Ra gene transfer potentiates BMP2-mediated bone healing by redirecting osteogenesis toward endochondral ossification	43
Targeting RNA oxidation by ISG20-mediated degradation is a potential therapeutic strategy for acute kidney injury	43
Preclinical studies in Krabbe disease: A model for the investigation of novel combination therapies for lysosomal storage diseases	43
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors	42
Single-cell RNA sequencing reveals anti-tumor potency of CD56+ NK cells and CD8+ T cells in humanized mice via PD-1 and TIGIT co-targeting	42
Building a novel TRUCK by harnessing the endogenous IFN-gamma promoter for cytokine expression	42
Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia	42
Innovative stroke intervention: Harnessing cerebral dopamine neurotrophic factor	41
Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2	41
AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription	41
Engineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders	41
Expanding CAR-engineered cell therapies into autoimmune diseases	39
CasRx-based Wnt activation promotes alveolar regeneration while ameliorating pulmonary fibrosis in a mouse model of lung injury	39
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations	39
An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation	38
Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing	38
Engineering small-molecule and protein drugs for targeting bone tumors	38
Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy	38
Regulatory approval of islet transplantation for treatment of type 1 diabetes: Implications and what is on the horizon	38
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection	37
Extracellular vesicle-transmitted miR-671-5p alleviates lung inflammation and injury by regulating the AAK1/NF-κB axis	37
Roles of lncRNAs in brain development and pathogenesis: Emerging therapeutic opportunities	37
The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors	37
Balancing activation and co-stimulation of CAR tunes signaling dynamics and enhances therapeutic potency	37
Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3	36
Microglial lnc-U90926 facilitates neutrophil infiltration in ischemic stroke via MDH2/CXCL2 axis	36
Macrophages as a therapeutic target to promote diabetic wound healing	36
In this issue	36
Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy	36
Activation of the YAP/KLF5 transcriptional cascade in renal tubular cells aggravates kidney injury	35
Biologics-based technologies for highly efficient and targeted RNA delivery	35
Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases	35
Inhibitory CARs fail to protect from immediate T cell cytotoxicity	35
Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles	35
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR	34
Advanced gene-editing strategy for epidermolysis bullosa simplex	34
TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling	34
Allele-specific CRISPR-Cas9 editing of dominant epidermolysis bullosa simplex in human epidermal stem cells	34
A new immune pathway mediating AAV immune responses	34

CTLA-4: Checkpoints beyond the membrane	34
In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition	33
The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism	33
The landscape of nanoparticle-based siRNA delivery and therapeutic development	33
A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors	33
FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program	33
Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors	33
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR	33
m6A RNA hypermethylation-induced BACE2 boosts intracellular calcium release and accelerates tumorigenesis of ocular melanoma	33
Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers	32
CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms	32
WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways	32
Efficient T cell adoptive transfer in lymphoreplete hosts mediated by transient activation of Stat5 signaling	32
Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies	31
Host liver-derived extracellular vesicles deliver miR-142a-3p induces neutrophil extracellular traps via targeting WASL to block the development of Schistosoma japonicum	31
Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo	31
Downregulation of a mitochondrial micropeptide, MPM, promotes hepatoma metastasis by enhancing mitochondrial complex I activity	31
Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma	31
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains	31
Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences	31
CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma	31
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations	31
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury	31
Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis	30
Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19	30
Defining the activity of pro-reparative extracellular vesicles in wound healing based on miRNA payloads and cell type-specific lineage mapping	30
PROTAC therapy as a new targeted therapy for lung cancer	30
Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing	30
Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma	29
The establishment of CDK9/RNA PolII/H3K4me3/DNA methylation feedback promotes HOTAIR expression by RNA elongation enhancement in cancer	29
An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation	29
Imagine CRISPR cures	29
Fecal miR-142a-3p from dextran sulfate sodium-challenge recovered mice prevents colitis by promoting the growth of Lactobacillus reuteri	29
Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8	29
Epigenetic strategies to boost CAR T cell therapy	29
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy	28
MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson’s disease	28
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials	28
Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin	28
Human cochlear diffusion from the cerebrospinal fluid space with gadolinium contrast	28
Precise excision of HTLV-1 provirus with a designer-recombinase	28
Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer	28
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs	27
Gsx1 promotes locomotor functional recovery after spinal cord injury	27
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke	27
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia	27
Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma	26
Long-term safety and efficacy of the fully human CAR-T therapy CT103A in relapsed/refractory multiple myeloma	26
Detection of chromosomal alteration after infusion of gene-edited allogeneic CAR T cells	26
Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach	26
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity	26
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models	26
The rise of cochlear gene therapy	26
Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo	26
CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma	26
Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-β receptor 1 recycling by stabilizing vimentin	26
Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas	26
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease	26
miRNAs as neuro-oncologic therapeutics: A narrative review	25
First in vivo base-editing trial shows promise	25
Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIV	25
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant	25
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma	25
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer	25
Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption	25
R-loops facilitate AAV-mediated nuclease-free gene targeting	25
Apoptotic MSCs, COX2/PGE2 and clinical efficacy in Crohn fistula	25
AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer’s disease mice	25
Longitudinal imaging of therapeutic enzyme expression after gene therapy for Fabry disease using positron emission tomography and the radiotracer [18F]AGAL	25
Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells	25
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expression	25
RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancers	25
In vivo genome editing shows promise for treating pulmonary diseases	25
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy	25
miRNA discovery to therapy: The field is sufficiently mature to assess the value of miRNA-based therapeutics	24
Evaluation of [18F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brain	24
Controlling intracellular protein delivery, tumor colonization and tissue distribution using flhDC in clinically relevant ΔsseJ Salmonella	24
Anti-microRNA-378a Enhances Wound Healing Process by Upregulating Integrin Beta-3 and Vimentin	24
Inverted HA-EV immunization elicits stalk-specific influenza immunity and cross-protection in mice	24
Getting the host antiviral machinery back on track: Targeting viral suppressors of RNA interference	24
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A	24
Retraction Notice to: Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells	24
Retraction Notice to: lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR	23
FOXC1 modulates stem-like cell properties and chemoresistance through hedgehog and EMT signaling in gastric adenocarcinoma	23
Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges	23
CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I	23
lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance inSCLC:Potentialmolecular panel for targeted therapy	23
Retraction Notice to: The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB	23
Retraction Notice to: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing	23
Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors	23
Retraction Notice to: Hypoxia-induced lncHILAR promotes renal cancer metastasis via ceRNA for the miR-613/206/ 1-1-3p/Jagged-1/Notch/CXCR4 signaling pathway	23
Retraction Notice to: Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF	23
Retraction Notice to: Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer	23
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2	23
Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery	23